高级检索
当前位置: 首页 > 详情页

Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study

文献详情

编号/登记号:
注册时间:
研究开始时间:
项目类型:
本院角色:
多中心研究:
招募状态:
研究疾病/适应症:
研究类型:
研究负责人:
研究单位: [1]Peking University Third Hospital [2]Suodi ZHAI [3]Shanghai Kaibao Pharmaceutical CO.,LTD. [4]Peking University [5]First Hospital of Handan City [6]Bethune International Peace Hospital of the Chinese PLA [7]The 254th Hospital of chinese People's Liberation Army [8]The 464th Hospital of chinese People's Liberation Army [9]People's Hospital of Cangzhou [10]The First Hospital of Qinhuangdao [11]The 44th Hospital of chinese People's Liberation Army [12]The First Affiliated Hospital of Kunming Medical College [13]The Second Affiliated Hospital of Kunming Medical University

研究目的:
Tanreqing Injection is widely used in respiratory disease with Chinese medicine syndrome of retention of phlegm and heat in Fei. This study record clinical use of Tanreqing Injection in the real world, observe the adverse drug reactions/ adverse drug events during treatment, and figure out why Tanreqing induced severe allergic reaction happens.

资源点击量:52537 今日访问量:0 总访问量:1562 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)